Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: Clinical study
Yf. Cheng et al., Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: Clinical study, WORLD J SUR, 24(7), 2000, pp. 844-850
Transarterial embolization (TAE) using various thrombotic substances for un
resectable hepatocellular carcinoma (HCC) performed on many patients has re
sulted in a better survival rate. We evaluated the efficacy and clinical sa
fety of using an Ethiodol-ethanol mixture as the embolizer for treatment of
HCC and the possibility of a surgical approach for inoperable tumors after
TAE, Twenty patients with HCC who underwent TAE and tumor resection were i
ncluded in the study. Initially, eight had increased retention rate of indo
cyanine green dye via intravenous injection (0.5 mg/kg) at 15 minutes (ICGR
15), and six had an insufficient residual volume that precluded them from u
ndergoing tumor resection. TAE was performed by slowly infusing the mixture
of Ethiodol and ethanol into the artery supplying the tumor until dual hep
atic artery and portal vein embolization was achieved. Serum levels of alan
ine amino-transferase increased after embolization, but all biochemistry st
udies reverted to normal within 2 weeks. A decreased tumor size (n = 15), i
mproved ICG (n = 8), and increased volume of the nonembolized lobe (n = 10)
were noted. The operations performed were right lobectomy (n = Ii), extend
ed right lobectomy (n = 3), left lobectomy (n = 2), extended left lobectomy
(n = 2), and wedge resection (n = 2), which included patients who did not
want to undergo major hepatectomy. Complete tumor necrosis,vas found in sev
en cases. All patients survived with no associated complications. The I-gea
r survival rate was 95%. Transarterial Ethiodol and ethanol administration
creating dual hepatic artery and portal vein embolization was a safe and ef
ficacious method far treating HCC it effectively decreases tumor size, caus
es compensatory hepatic hypertrophy, and improves the ICCR15, which allows
a wider range of patients to undergo liver surgery and achieve better survi
val.